Eleven firms gave Surgery Partners a "buy" rating, according to Baseball News Source.
Here are four notes:
1. The analysts have a 12-month price target of $22.44 on Surgery Partner shares.
2. Zacks recently upgraded company shares form a "sell" to a "buy" rating.
3. On Oct. 11, Surgery Partners shares plummeted 1.11 percent, trading at $19.98 per share.
4. The company has a 50-day moving average of $19.33 and 200-day moving average of $16.69.
More articles on surgery centers:
Jefferies analysts weigh in on SCA shares: 3 notes
Surgical Care Affiliates to refinance term loan facility and obtain incremental term loan: 4 thoughts
3 recent ASC acquisitions — October 6, 2016